# Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/afatinib-versus-cisplatin-based-chemotherapy-for-egfr-mutation-positive-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Chih‐Hsin Yang,Yi‐Long Wu,Martin Schüler,Martin Sebastian,Sanjay Popat,Nobuyuki Yamamoto,Caicun Zhou,Cheng-Ping Hu,Kenneth J. O’Byrne,Jifeng Feng,Shun Lü,Yunchao Huang,Sarayut Lucien Geater,Kye Young Lee,Chun-Ming Tsai,В. А. Горбунова,Vera Hirsh,Jaafar Bennouna,С. В. Орлов,Tony Mok,Michael Boyer,Wu‐Chou Su,Ki Hyeong Lee,Terufumi Kato,Dan Massey,Mehdi Shahidi,Victoria Zazulina,Lecia V. Sequist |
| Citations | 1,585 |
| DOI | 10.1016/s1470-2045(14)71173-8 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2132870547 |
| PMID | 25589191 |
| Type | article |
| Year | 2015 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Nobuyuki Yamamoto](https://scholariq.org/researchers/nobuyuki-yamamoto/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)
- [Lecia V. Sequist](https://scholariq.org/researchers/lecia-v-sequist/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.